You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Buckle up: It’s time for the FDA to face another major political test
Before Aduhelm, Billy Dunn was a superstar at the FDA
Billy Dunn, the regulator at the center of the FDA’s decision on Aduhelm, was a shining star at the agency before that saga, according to new records obtained by STAT.